Risk factors for severe COVID-associated lung damage in patients with chronic obstructive pulmonary disease
Meditsinskiy sovet = Medical Council · 14.07.2026 · (9) · 86-96
DOI: 10.21518/ms2026-234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 14.07.2026. Verfasst von T. Yu. Gneusheva und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Introduction
Concomitant chronic obstructive pulmonary disease (COPD) is one of the most important risk factors for the development of COVID-associated lung damage.
Aim
To study risk factors for the development of severe COVID-associated lung damage in patients with COPD. Materials and methods . A retrospective single-center comparative study was conducted. The study included 154 patients hospitalized for COVID-19, of which 103 patients had COPD. The comparison group consisted of patients (n = 51) without COPD and smoking history on the case-control principle. The presence of COVID-19 was confirmed by laboratory tests and/or clinically and radiologically. The dynamics of clinical and laboratory-instrumental indicators were evaluated from the first to the seventh day of observation.
Results
In the COVID-19 group without COPD, the proportion of patients with lung damage CT 1–2 and CT 3–4 was 47% (18/38), in the COVID-19 and COPD group – 38% (39/103); no statistically significant differences were found (p = 0.41). Lung damage CT 3–4 regardless of the presence/absence of COPD was statistically significantly associated with older age, higher body mass index, coronary artery disease, increased levels of blood pressure, respiratory rate, neutrophils, CRP, AST, LDH, and decreased SpO 2 level. In the group of patients with COVID-19 and COPD, lung damage CT 3–4 was associated with higher values of these indicators than in the group of patients with COVID-19 without COPD: the threshold value of leukocytes in the COVID-19 group without COPD was 5.6 × 10 9 /L versus 10.9 × 10 9 /L in patients with COVID-19 and COPD, the threshold value of neutrophils – 4.2 × 10 9 /L and 9.3×10 9 /L, the threshold value of the neutrophil/lymphocyte ratio – 5.8 and 11.3. Lung damage CT 3–4 in patients with COVID-19 and COPD was associated with higher mMRC scores (odds ratio [OR] = 2.75 [95% CI: 1.09–6.92] for 3 points versus 2, OR = 4.24 [95% CI: 1.26–14.3] for 4 points versus 2), higher CAT scores (OR = 4.87; 95% CI: 1.88–13.53 for CAT above 18 points) and mixed COPD phenotype (OR = 2.94; 95% CI: 1.10–8.07) versus bronchitic (p = 0.045).
Conclusion
Severe COVID-associated lung damage (CT 3–4) develops under the influence of general factors (age, obesity, inflammation, hypoxemia), but in patients with COPD it occurs against the background of more pronounced systemic inflammation and is aggravated by symptoms of the underlying disease.
Zitieren
APA
Gneusheva, T. Y., Gaynitdinova, V. V., Pozdnyakova, A. A., Aynetdinova, E. S., & Wang, Y. (2026). Risk factors for severe COVID-associated lung damage in patients with chronic obstructive pulmonary disease. Meditsinskiy sovet = Medical Council, 86-96. https://doi.org/10.21518/ms2026-234
Vancouver
Gneusheva TY, Gaynitdinova VV, Pozdnyakova AA, Aynetdinova ES, Wang Y. Risk factors for severe COVID-associated lung damage in patients with chronic obstructive pulmonary disease. Meditsinskiy sovet = Medical Council. 2026:86-96. doi:10.21518/ms2026-234
BibTeX
@article{Gneusheva2026,
author = {Gneusheva, T. Yu. and Gaynitdinova, V. V. and Pozdnyakova, A. A. and Aynetdinova, E. S. and Wang, Yu.},
title = {Risk factors for severe COVID-associated lung damage in patients with chronic obstructive pulmonary disease},
journal = {Meditsinskiy sovet = Medical Council},
year = {2026},
number = {9},
pages = {86--96},
doi = {10.21518/ms2026-234}
}
EUVIMED